483 Document: Teva Pharmaceuticals, Jun 30, 2016

FDANews 483 Teva Pharmaceuticals Jun 30 2016 top
Craig D. Zagata FDA Investigator Marcelo O. Mangalindan FDA Investigator

On Jun 30, 2016, the FDA inspected Teva Pharmaceuticals's Horsham site. Explore the inspectional observations.